BioLoomics

Boulder, CO · Founded 2019 · Privately Held (backing)

Developer of antibody-based therapeutics designed for enhanced drug delivery in oncology. BioLoomics is based in Boulder, CO and was founded in 2019. Its last reported valuation was $22.4 million in Mar 2023. It has raised $10.4 million across 4 recorded rounds; the latest was a $450,000 seed round in Aug 2025.

Last reported valuation
$22.4M
Oct 2026
Priced at
—
Total raised
$10.4M
Last round
Seed Round
Aug 2025
What is BioLoomics worth?
$22.4Mlast reported valuation · Oct 2026

BioLoomics's last reported valuation, Mar 2023. Nothing priced has surfaced since.

Free account
More of BioLoomics with a free account
  • ·The complete investor list: 12 names
  • ·Watch BioLoomics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

BioLoomics funding history

4 rounds
DateRoundRaisedPost-money
Aug 2025Seed Round$450K▮
Feb 2023Early Stage VC$9.3M▮
May 2021Seed Round$575K▮
May 2019Seed Round$600K▮
Unlock post-money valuations

Membership and data by Private Market View

BioLoomics valuation

BioLoomics's last reported valuation was $22.4 million in Mar 2023. No priced round, secondary trade or fund mark has surfaced since.

How much has BioLoomics raised?

BioLoomics has raised $10.4 million across 4 recorded rounds since 2019. The largest was a $9.3 million early-stage round in Feb 2023; the most recent was a $450,000 seed round in Aug 2025.

BioLoomics has filed 3 Form Ds with the SEC since 2019, most recently in Mar 2023 ($9.3 million sold to 23 investors).

How BioLoomics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For BioLoomics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about BioLoomics

What is BioLoomics worth?
BioLoomics is valued at $22.4M as of Oct 2026. BioLoomics's last reported valuation, Mar 2023. Nothing priced has surfaced since.
How much has BioLoomics raised?
BioLoomics has raised $10.4M in total funding across 4 recorded rounds.
When did BioLoomics last raise?
BioLoomics last raised in Aug 2025 (Seed Round), raising $450K.